BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2022
View Archived Issues
PIK3C2B variants impact mTOR pathway and lead to lipid signaling-driven focal epilepsy
Read More
Cytokine promotes heart repair after infarct
Read More
Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates
Read More
CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia
Read More
Magmas inhibition as new therapeutic strategy in medulloblastoma
Read More
Novel humanized mouse model of posterior fossa A ependymoma
Read More
New MRGPRX2 antagonists identified at Bioardis
Read More
Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors
Read More
2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors
Read More
Anti-glypican-3 antibody-drug conjugates developed at Ardeagen
Read More
RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates
Read More
Studies explore asprosin as a target for treating binge eating
Read More
Lenire licenses VSN-16R from UCL for fragile X syndrome
Read More
Heterozygous mutations in TMEM163 cause hypomyelinating leukodystrophy
Read More
